XT
GLUE icon

XTX Topco’s Monte Rosa Therapeutics GLUE Stock Holding History

XTX Topco’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$965K Sell
39,875
-17,884
-31% -$338K 0.01% 1825
2026
Q1 		$950K Buy
57,759
+26,634
+86% +$509K 0.02% 1455
2025
Q4 		$488K Sell
31,125
-19,003
-38% -$256K 0.01% 1624
2025
Q3 		$371K Sell
50,128
-4,312
-8% -$22.8K 0.02% 1329
2025
Q2 		$246K Buy
+54,440
New +$243K 0.01% 1564

Other funds holding GLUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco's GLUE Position: Q2 2026 in Review

XTX Topco reduced its Monte Rosa Therapeutics (GLUE) stake by 31% in Q2 2026, selling an estimated $338K and leaving 39,875 shares worth $965K. The position accounts for 0.01% of the portfolio, ranked #1825.

XTX Topco first reported a position in GLUE in Q2 2025 and has held it in 5 quarters since. 192 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • XTX Topco held 39,875 shares of Monte Rosa Therapeutics worth $965K as of Q2 2026.
  • XTX Topco sold 17,884 Monte Rosa Therapeutics shares in Q2 2026, an estimated $338K.
  • Monte Rosa Therapeutics made up 0.01% of XTX Topco's portfolio in Q2 2026, its #1825 holding.
  • XTX Topco first reported a position in Monte Rosa Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 192 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.